What are the possible diagnoses for a patient with low complement C3 (0.74) and C4 (0.15), normal urea, negative antinuclear antibody (ANA), negative extractable nuclear antigen (ENA), negative anti‑cyclic citrullinated peptide (anti‑CCP), normal C‑reactive protein (CRP) and erythrocyte sedimentation rate (ESR), widespread joint pain and swelling affecting knees, ankles, feet, toes, wrists, elbows and fingers, a malar rash, oral ulcers, fatigue, and Raynaud’s phenomenon?

Differential Diagnosis: ANA-Negative Lupus vs. Seronegative Rheumatoid Arthritis vs. Other Systemic Inflammatory Conditions

This clinical presentation most strongly suggests ANA-negative systemic lupus erythematosus (SLE), given the constellation of low complement levels (C3 0.74, C4 0.15), malar rash, oral ulcers, Raynaud's phenomenon, and polyarthritis—despite negative ANA, ENA, and anti-CCP antibodies.

Primary Diagnostic Considerations

1. ANA-Negative Systemic Lupus Erythematosus (Most Likely)

The combination of hypocomplementemia with malar rash, oral ulcers, and Raynaud's phenomenon is highly characteristic of SLE, even with negative ANA 1, 2, 3. Key supporting evidence:

• Low C3 and C4 are strongly associated with SLE activity 1, 2, 4. Studies show C3 <0.785 g/L and C4 <0.145 g/L have 77.9% and 80.1% sensitivity for SLE diagnosis respectively 2
• Simultaneously low C3 AND C4 occurs in 73.42% of SLE patients but is much less common in other rheumatic diseases 2
• ANA-negative SLE exists in 3-5% of cases 3, 5. The negative ANA does not exclude lupus when other clinical and serological features are present
• The malar rash, oral ulcers, and Raynaud's phenomenon are classic SLE manifestations rarely seen together in other conditions
• Normal CRP/ESR with active disease is characteristic of SLE, whereas RA typically shows elevated inflammatory markers 1

Critical pitfall: Do not dismiss SLE based solely on negative ANA. Hypocomplementemia with classic clinical features (malar rash, oral ulcers) should prompt SLE workup regardless of ANA status 2, 3.

2. Seronegative Rheumatoid Arthritis (Less Likely)

While the widespread polyarticular involvement with visible finger joint swelling could suggest RA, several features argue against this diagnosis 6:

• Negative anti-CCP and RF (scores 0 points in ACR/EULAR criteria) 6
• Normal CRP and ESR (scores 0 points) 6. RA typically shows elevated acute phase reactants, with CRP positively correlating with disease activity 1
• Low complement levels are atypical for RA. Studies show RA patients have normal or elevated C3/C4, not decreased 1
• Malar rash, oral ulcers, and Raynaud's are not RA features 6

Even with >10 joints involved (5 points) and symptoms >6 weeks (1 point), this patient scores only 6/10 on ACR/EULAR criteria—the minimum threshold, but the atypical serological and clinical features make RA unlikely 6.

3. Mixed Cryoglobulinemia Syndrome

Low C4 with normal C3 can suggest cryoglobulinemia, but this patient has low C3 AND C4 7. Mixed cryoglobulinemia typically presents with:

• Purpura, weakness, arthralgias (classic triad)
• Low C4 often with normal C3
• Associated with HCV infection (not mentioned here)
• The malar rash and oral ulcers are not typical features 7

Serum cryoglobulins should be tested, but the clinical picture fits SLE better than isolated cryoglobulinemia 7.

4. Undifferentiated Connective Tissue Disease (UCTD)

This remains a possibility if the patient doesn't fully meet SLE criteria, but the combination of hypocomplementemia, malar rash, oral ulcers, and Raynaud's makes incomplete/evolving SLE more likely than UCTD 8.

5. Other Considerations (Lower Priority)

• Complement deficiency syndromes: Would show persistently low complements but wouldn't explain the malar rash and oral ulcers 9
• Drug-induced lupus: Consider medication history, though typically ANA-positive
• Overlap syndromes: Possible but less common than primary SLE

Recommended Diagnostic Workup

Immediate investigations needed:

1. Anti-dsDNA antibodies (if not already done)—positive in 60-70% of SLE, highly specific 3, 4
2. Complete blood count with differential—look for cytopenias (leukopenia, lymphopenia, thrombocytopenia)
3. Urinalysis with microscopy—assess for proteinuria, cellular casts (lupus nephritis)
4. Anti-Smith antibodies—highly specific for SLE even when ANA negative
5. Serum cryoglobulins—to exclude cryoglobulinemia 7
6. Repeat ANA testing using different methodology (ELISA vs. immunofluorescence)—ANA can be falsely negative 5, 10
7. Direct Coombs test—if anemia present
8. Hand and foot radiographs—assess for erosive changes (would favor RA over SLE)

Secondary investigations if initial workup inconclusive:

• Anti-Ro/SSA and anti-La/SSB antibodies (can be positive in ANA-negative lupus) 11
• Skin biopsy of malar rash (lupus band test)
• Renal biopsy if proteinuria present
• Antiphospholipid antibodies (lupus anticoagulant, anticardiolipin, anti-β2-glycoprotein I)

Clinical Management Approach

Given the high suspicion for SLE with potential organ involvement:

1. Urgent rheumatology referral is mandatory—this patient requires specialist evaluation within 1-2 weeks 6
2. Do not delay treatment pending complete serological workup if clinical features strongly suggest active SLE with organ involvement
3. Monitor renal function closely—lupus nephritis can develop rapidly
4. Avoid NSAIDs alone—insufficient for inflammatory arthritis and may worsen renal function 12
5. Consider hydroxychloroquine as first-line therapy for SLE arthritis and constitutional symptoms
6. Corticosteroids may be needed depending on disease severity and organ involvement

Key Clinical Pearls

• Hypocomplementemia (low C3 AND C4) with normal inflammatory markers (CRP/ESR) strongly favors SLE over RA 1, 2
• ANA negativity occurs in 3-5% of SLE cases—do not exclude diagnosis based on this alone 3, 5
• The combination of malar rash + oral ulcers + Raynaud's + polyarthritis is virtually pathognomonic for SLE when other causes excluded
• Complement levels correlate with SLE disease activity—falling C3/C4 suggests active disease or flare 2, 4
• Seronegative RA (negative RF and anti-CCP) with normal inflammatory markers is uncommon—reconsider diagnosis 6